Literature DB >> 25502592

Parameters influencing in-hospital mortality in patients hospitalized in intensive cardiac care unit: is there an influence of anemia and iron deficiency?

Ewa Uscinska1, Bozena Sobkowicz, Robert Sawicki, Izabela Kiluk, Malgorzata Baranicz, Tomasz Stepek, Milena Dabrowska, Maciej Szmitkowski, Wlodzimierz J Musial, Agnieszka M Tycinska.   

Abstract

We investigated the incidence and prognostic value of anemia as well as of the iron status in non-selected patients admitted to an intensive cardiac care unit (ICCU). 392 patients (mean age 70 ± 13.8 years, 43% women), 168 with acute coronary syndromes (ACS), 122 with acute decompensated heart failure, and 102 with other acute cardiac disorders were consecutively, prospectively assessed. The biomarkers of iron status-serum iron concentration (SIC), total iron binding capacity (TIBC), and transferrin saturation (TSAT) together with standard clinical, biochemical and echocardiographic variables-were analyzed. In-hospital mortality was 3.8% (15 patients). The prevalences of anemia (according to WHO criteria), and iron deficiency (ID) were 64 and 63%, respectively. The level of biomarkers of iron status, but not anemia, was lower in patients who died (p < 0.05). Anemia was less frequent in patients with ACS as compared to the remaining ICCU population (p = 0.019). The analysis by logistic regression indicated the highest risk of death for age [odds ratio (OD) 1.38, 95% CI 1.27-1.55], SIC (OR 0.85, 95% CI 0.78-0.94), TIBC (OR 0.95, 95% CI 0.91-0.98), left ventricle ejection fraction (OR 0.85, 95% CI 0.77-0.93), as well as hospitalization for non-ACS (OR 0.25, 95% CI 0.14-0.46), (p < 0.05). The risk of death during hospitalization tended to increase with decreasing levels of TIBC (p = 0.49), as well as with the absence of ACS (p = 0.54). The incidence of anemia and ID in heterogeneous ICCU patients is high. Parameters of the iron status, but not anemia per se, independently influence in-hospital mortality. The prevalence of anemia is higher in non-ACS patients, and tends to worsen the prognosis.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25502592     DOI: 10.1007/s11739-014-1170-8

Source DB:  PubMed          Journal:  Intern Emerg Med        ISSN: 1828-0447            Impact factor:   3.397


  28 in total

Review 1.  Anemia of chronic disease.

Authors:  Guenter Weiss; Lawrence T Goodnough
Journal:  N Engl J Med       Date:  2005-03-10       Impact factor: 91.245

2.  [The prevalence of anemia and its impact on hospitalization mortality in patients with acute heart failure].

Authors:  R Miklík; M Felsöci; J Parenica; D Tomcíková; J Jarkovský; J Spinar
Journal:  Vnitr Lek       Date:  2010-05

3.  Anemia is associated with worse symptoms, greater impairment in functional capacity and a significant increase in mortality in patients with advanced heart failure.

Authors:  Tamara B Horwich; Gregg C Fonarow; Michele A Hamilton; W Robb MacLellan; Jeff Borenstein
Journal:  J Am Coll Cardiol       Date:  2002-06-05       Impact factor: 24.094

4.  Disordered iron homeostasis in chronic heart failure: prevalence, predictors, and relation to anemia, exercise capacity, and survival.

Authors:  Darlington O Okonko; Amit K J Mandal; Constantinos G Missouris; Philip A Poole-Wilson
Journal:  J Am Coll Cardiol       Date:  2011-09-13       Impact factor: 24.094

5.  A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group.

Authors:  A S Levey; J P Bosch; J B Lewis; T Greene; N Rogers; D Roth
Journal:  Ann Intern Med       Date:  1999-03-16       Impact factor: 25.391

Review 6.  Anemia and aging: an overview of clinical, diagnostic and biological issues.

Authors:  R Carmel
Journal:  Blood Rev       Date:  2001-03       Impact factor: 8.250

7.  Recovery from hospital-acquired anemia after acute myocardial infarction and effect on outcomes.

Authors:  Adam C Salisbury; Mikhail Kosiborod; Amit P Amin; Kimberly J Reid; Karen P Alexander; John A Spertus; Frederick A Masoudi
Journal:  Am J Cardiol       Date:  2011-07-23       Impact factor: 2.778

8.  Anemia is common in heart failure and is associated with poor outcomes: insights from a cohort of 12 065 patients with new-onset heart failure.

Authors:  Justin A Ezekowitz; Finlay A McAlister; Paul W Armstrong
Journal:  Circulation       Date:  2003-01-21       Impact factor: 29.690

Review 9.  Iron metabolism in the anemia of chronic disease.

Authors:  Günter Weiss
Journal:  Biochim Biophys Acta       Date:  2008-08-22

Review 10.  Ferritin, iron homeostasis, and oxidative damage.

Authors:  Paolo Arosio; Sonia Levi
Journal:  Free Radic Biol Med       Date:  2002-08-15       Impact factor: 7.376

View more
  3 in total

1.  Relevance of pre-existing anaemia for patients admitted for acute coronary syndrome to an intensive care unit: a retrospective cohort analysis of 7418 patients.

Authors:  Patricia Wischmann; Raphael Romano Bruno; Bernhard Wernly; Georg Wolff; Shazia Afzal; Richard Rezar; Mareike Cramer; Nadia Heramvand; Malte Kelm; Christian Jung
Journal:  Eur Heart J Open       Date:  2022-06-15

2.  Anemia in patients with high-risk acute coronary syndromes admitted to Intensive Cardiac Care Units.

Authors:  Victòria Lorente; Jaime Aboal; Cosme Garcia; Jordi Sans-Roselló; Antonia Sambola; Rut Andrea; Carlos Tomás; Gil Bonet; David Viñas; Nabil El Ouaddi; Santiago Montero; Javier Cantalapiedra; Margarida Pujol; Isabel Hernández; María Pérez-Rodriguez; Isaac Llaó; José C Sánchez-Salado; Miquel Gual; Albert Ariza-Solé
Journal:  J Geriatr Cardiol       Date:  2020-01       Impact factor: 3.327

3.  Iron metabolism imbalance at the time of listing increases overall and infectious mortality after liver transplantation.

Authors:  Elodie Fallet; Michel Rayar; Amandine Landrieux; Christophe Camus; Pauline Houssel-Debry; Caroline Jezequel; Ludivine Legros; Thomas Uguen; Martine Ropert-Bouchet; Karim Boudjema; Dominique Guyader; Edouard Bardou-Jacquet
Journal:  World J Gastroenterol       Date:  2020-04-28       Impact factor: 5.742

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.